학술논문

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.
Document Type
Article
Source
Nature Communications; 5/1/2020, Vol. 11 Issue 1, p1-14, 14p
Subject
BRAF genes
RENAL cell carcinoma
ANIMAL models in research
TUMOR microenvironment
CARCINOMA
PHENOTYPES
PROGRAMMED cell death 1 receptors
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)